{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:09:06Z","timestamp":1776722946484,"version":"3.51.2"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"DOI":"10.7759\/cureus.104469","type":"journal-article","created":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T08:27:11Z","timestamp":1772353631000},"source":"Crossref","is-referenced-by-count":1,"title":["Pembrolizumab and Nivolumab-Induced Late Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): A Case Report"],"prefix":"10.7759","author":[{"given":"Ahmed","family":"Alqefari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulelah A","family":"Aldossari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Y","family":"Almohaimeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid A","family":"Aldossari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayoub","family":"Almohaimeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naif","family":"Aldossari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala","family":"Elsaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59804","article-title":"Atypical presentation of drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient on pembrolizumab: a case report","volume":"16","author":"Tran H","year":"2024","unstructured":"Tran H, Bhatt G. Atypical presentation of drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient on pembrolizumab: a case report. Cureus. 2024, 16:e59804. 10.7759\/cureus.59804","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_582_17","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms: An Update and Review of Recent Literature","volume":"63","author":"De A","year":"2018","unstructured":"De A, Rajagopalan M, Sarda A, Das S, Biswas P. Drug Reaction with Eosinophilia and Systemic Symptoms: An Update and Review of Recent Literature. Indian J Dermatol. 2018, 63:30-40. 10.4103\/ijd.IJD_582_17","journal-title":"Indian J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.02.008","article-title":"Pembrolizumab-induced bullous pemphigoid","volume":"5","author":"Sun CW","year":"2019","unstructured":"Sun CW, Grossman SK, Aphale A, Hsu S. Pembrolizumab-induced bullous pemphigoid. JAAD Case Rep. 2019, 5:362-4. 10.1016\/j.jdcr.2019.02.008","journal-title":"JAAD Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.20517\/2394-4722.2020.77","article-title":"Nivolumab-induced severe bullous pemphigoid in a patient with renal cancer: a case report and literature review","volume":"6","author":"Wu X","year":"2020","unstructured":"Wu X, Palvai S, Jalil A. Nivolumab-induced severe bullous pemphigoid in a patient with renal cancer: a case report and literature review. J Cancer Metastasis Treat. 2020, 6:40. 10.20517\/2394-4722.2020.77","journal-title":"J Cancer Metastasis Treat"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002879","article-title":"Nivolumab-associated DRESS in a genetic susceptible individual","volume":"9","author":"Ai L","year":"2021","unstructured":"Ai L, Gao J, Zhao S, et al.. Nivolumab-associated DRESS in a genetic susceptible individual. J Immunother Cancer. 2021, 9:e002879. 10.1136\/jitc-2021-002879","journal-title":"J Immunother Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun SH","year":"2007","unstructured":"Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, Roujeau JC. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol. 2007, 156:609-11. 10.1111\/j.1365-2133.2006.07704.x","journal-title":"Br J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun SH","year":"2013","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L, et al.. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013, 169:1071-80. 10.1111\/bjd.12501","journal-title":"Br J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.11.017","article-title":"Nivolumab-associated DRESS syndrome: a case report","volume":"5","author":"Lu J","year":"2019","unstructured":"Lu J, Thuraisingam T, Chergui M, Nguyen K. Nivolumab-associated DRESS syndrome: a case report. JAAD Case Rep. 2019, 5:216-8. 10.1016\/j.jdcr.2018.11.017","journal-title":"JAAD Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3126\/njms.v10i1.77639","article-title":"Nivolumab associated DRESS syndrome: a case report","volume":"10","author":"Paudel U","year":"2025","unstructured":"Paudel U, Parajuli S. Nivolumab associated DRESS syndrome: a case report. Nep J Med Sci. 2025, 10:55-9. 10.3126\/njms.v10i1.77639","journal-title":"Nep J Med Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000326","article-title":"Checkpoint inhibitor-associated drug reaction with eosinophilia and systemic symptom syndrome","volume":"27","author":"Mirza S","year":"2017","unstructured":"Mirza S, Hill E, Ludlow SP, Nanjappa S. Checkpoint inhibitor-associated drug reaction with eosinophilia and systemic symptom syndrome. Melanoma Res. 2017, 27:271-3. 10.1097\/CMR.0000000000000326","journal-title":"Melanoma Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpccr.2021.100133","article-title":"Pembrolizumab-induced massive hypereosinophilia associated with mononeuritis multiplex, brain microvascular lesions and intestinal eosinophilic infiltration in a melanoma patient","volume":"4","author":"Dao K","year":"2021","unstructured":"Dao K, Kuntzer T, Maeder P, Frossard V, Livio F. Pembrolizumab-induced massive hypereosinophilia associated with mononeuritis multiplex, brain microvascular lesions and intestinal eosinophilic infiltration in a melanoma patient. Curr Probl Cancer C R. 2021, 4:100133. 10.1016\/j.cpccr.2021.100133","journal-title":"Curr Probl Cancer C R"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/419760-pembrolizumab-and-nivolumab-induced-late-drug-reaction-with-eosinophilia-and-systemic-symptoms-dress-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T08:27:12Z","timestamp":1772353632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/419760-pembrolizumab-and-nivolumab-induced-late-drug-reaction-with-eosinophilia-and-systemic-symptoms-dress-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.104469","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}